Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 745 | 475 | 228 | 80 | -1,220 |
| Depreciation Amortization | 1,256 | 941 | 614 | 316 | 1,475 |
| Accounts receivable | -379 | -282 | -470 | -203 | 199 |
| Accounts payable and accrued liabilities | 112 | 76 | -95 | 96 | 14 |
| Other Working Capital | -615 | -951 | -1,009 | -108 | 512 |
| Other Operating Activity | 386 | 299 | 628 | 136 | -146 |
| Operating Cash Flow | $1,504 | $559 | $-103 | $317 | $834 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -268 | -118 | -54 | -41 | -163 |
| Net Acquisitions | N/A | N/A | N/A | -141 | -450 |
| Sale Of Investment | 40 | 40 | 40 | 40 | 93 |
| Other Investing Activity | -713 | -524 | -360 | -169 | -811 |
| Investing Cash Flow | $-940 | $-602 | $-374 | $-310 | $-1,331 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 155 | N/A | -180 |
| Common Stock Issued | 21 | 18 | 18 | N/A | 187 |
| Other Financing Activity | -67 | -50 | -33 | -17 | -67 |
| Financing Cash Flow | $-46 | $-32 | $140 | $-17 | $-60 |
| Beginning Cash Position | 679 | 679 | 679 | 679 | 1,236 |
| End Cash Position | 1,198 | 605 | 343 | 670 | 679 |
| Net Cash Flow | $518 | $-75 | $-337 | $-10 | $-557 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,504 | 559 | -103 | 317 | 834 |
| Capital Expenditure | -268 | -118 | -54 | -41 | -163 |
| Free Cash Flow | 1,237 | 441 | -157 | 276 | 671 |